2024 / 02

Next Paper
DOI: 10.47183/mes.2024.022

ORIGINAL RESEARCH

The impact of polymorphisms in antioxidant genes on the risk of malignant neoplasm development in exposed individuals

Blinova EA, Korechenkova AV, Yanishevskaya MA, Akleyev AV
About authors

Urals Research Center for Radiation Medicine of the Federal Medical Biological Agency, Chelyabinsk, Russia

Correspondence should be addressed: Eugenia A. Blinova
Vorovsky, 68-А, Chelyabinsk, 454141, Russia; ur.mrcru@avonilb

About paper

Funding: the paper was prepared during implementation of a part of the research project (contract No. 635/FMBC/23 dated 29.11.2023).

Author contributions: Blinova EA — developing the method, manuscript writing; Korechenkova AV — statistical data processing, manuscript writing; Yanishevskaya MA — laboratory tests, manuscript writing; Akleyev AV — study conception and design, manuscript writing, academic advising.

Compliance with ethical standards: all the subjects submitted the form of the informed consent to study participation and biomaterial sampling and storage in the tissue bank finalized in the study protocol approved by the Ethics Committee of the Urals Research Center for Radiation Medicine of FMBA of Russia (protocol No. 2 dated 13 April 2023) before inclusion in the study.

Received: 2024-03-25 Accepted: 2024-06-03 Published online: 2024-06-26
|
  1. Buonanno M, de Toledo SM, Pain D, Azzam EI. Long-term consequences of radiation-induced bystander effects depend on radiation quality and dose and correlate with oxidative stress. Radiat Res. 2011; 175 (4): 405–15. DOI: 10.1667/RR2461.1.
  2. Sage E, Shikazono N. Radiation-induced clustered DNA lesions: repair and mutagenesis. Free Radic Biol Med. 2017; (107): 125– 35. DOI: 10.1016/j.freeradbiomed.2016.12.008.
  3. Abd El Azeem RA, Zedan MM, Saad EA, Mutawi TM, Attia ZR. Single-nucleotide polymorphisms (SNPs) of antioxidant enzymes SOD2 and GSTP1 genes and SLE risk and severity in an Egyptian pediatric population. Clin Biochem. 2021; (88): 37–42. DOI: 10.1016/j.clinbiochem.2020.11.010.
  4. Nikic P, Dragicevic D, Jerotic D, Savic S, Djukic T, Stankovic B, et al. Polymorphisms of antioxidant enzymes SOD2 (rs4880) and GPX1 (rs1050450) are associated with bladder cancer risk or its aggressiveness. Medicina (Kaunas). 2023; 59 (1): 131. DOI: 10.3390/medicina59010131.
  5. Nawab SN, Zehra S, Fawwad A, Azhar A. A study on catalase gene promoter polymorphism-21 A/T (rs7943316) in healthy Pakistani population. Pak J Med Sci. 2017; 33 (6): 1521–4. DOI: 10.12669/pjms.336.13188.
  6. Taioli E, Benhamou S, Bouchardy C, Cascorbi I, Cajas-Salazar N, Dally H, et al. Myeloperoxidase G-463A polymorphism and lung cancer: a HuGE genetic susceptibility to environmental carcinogens pooled analysis. Genet Med. 2007; 9 (2): 67–73. DOI: 10.1097/gim.0b013e31803068b1.
  7. Kumar R, Kohli S, Ali Z, Duhan K, Ram R, Gupta M, et al. CYBA (p22phox) variants associate with blood pressure and oxidative stress markers in hypertension: a replication study in populations of diverse altitudes. Hypertens Res. 2015; 38 (7): 498–506. DOI: 10.1038/hr.2015.31.
  8. Akleev AV, Kiselev MF, redaktory. Mediko-biologicheskie i jekologicheskie posledstvija radioaktivnogo zagrjaznenija reki Techa. M.: Vtoraja tipografija FU "Medbiojekstrem", 2001; 531 p. Russian.
  9. Degteva MO, Nape BA, Tolstyh EI, Shishkina EA, Bugrov NG, Krestinina LJu, et al. Raspredelenie individual'nyh doz v kogorte ljudej, obluchennyh v rezul'tate radioaktivnogo zagrjaznenija reki Techi. Medicinskaja radiologija i radiacionnaja bezopasnost'. 2019; 64 (3): 46–53. DOI: 10.12737/article_5cf2364cb49523.98590475. Russian.
  10. Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics. 2003; 19 (3): 376–82. DOI: 10.1093/bioinformatics/btf869.
  11. Burmistrova AL, redaktor. Metaorganizm. Stress i adaptacija. Cheljabinsk: Cheljabinskij gosudarstvennyj universitet, 2019; 239 p. Russian.
  12. Ďuračková Z. Some current insights into oxidative stress. Physiol Res. 2010; 59 (4): 459–69. DOI: 10.33549/physiolres.931844.
  13. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 2010; 49 (11): 1603–16. DOI: 10.1016/j.freeradbiomed.2010.09.006.
  14. Khandrika L, Kumar B, Koul S, Maroni P, Koul HK. Oxidative stress in prostate cancer. Cancer Lett. 2009; 282 (2): 125–36. DOI: 10.1016/j.canlet.2008.12.011.
  15. Córdoba EE, Abba MC, Lacunza E, Fernánde E, Güerci AM. Polymorphic variants in oxidative stress genes and acute toxicity in breast cancer patients receiving radiotherapy. Cancer Res Treat. 2016; 48 (3): 948–54. DOI: 10.4143/crt.2015.360.
  16. Burri RJ, Stock RG, Cesaretti JA, Atencio DP, Peters S, Peters CA, et al. Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer. Radiat Res. 2008; 170 (1): 49–59. DOI: 10.1667/RR1219.1.
  17. Bastaki M, Huen K, Manzanillo P, Chande N, Chen C, Balmes JR, et al. Genotype-activity relationship for Mn-superoxide dismutase, glutathione peroxidase 1 and catalase in humans. Pharmacogenet Genomics. 2006; 16 (4): 279–86. DOI: 10.1097/01.fpc.0000199498.08725.9c.
  18. Sutton A, Imbert A, Igoudjil A, Descatoire V, Cazanave S, Pessayre D, et al. The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet Genomics. 2005; 15 (5): 311–9. DOI: 10.1097/01213011-200505000-00006.
  19. Zhao Y, Wang H, Zhou J, Shao Q. Glutathione peroxidase GPX1 and its dichotomous roles in cancer. Cancers (Basel). 2022; 14 (10): 2560. DOI: 10.3390/cancers14102560.
  20. Chen J, Cao Q, Qin C, Shao P, Wu Y, Wang M, et al. GPx-1 polymorphism (rs1050450) contributes to tumor susceptibility: evidence from meta-analysis. J Cancer Res Clin Oncol. 2011; 137 (10): 1553–61. DOI: 10.1007/s00432-011-1033-x.
  21. Tupurani MA, Padala C, Puranam K, Galimudi RK, Kupsal K, Shyamala N, et al. Association of CYBA gene (-930 A/G and 242 C/T) polymorphisms with oxidative stress in breast cancer: a case-control study. PeerJ. 2018; (6): e5509. DOI: 10.7717/peerj.5509.